NAD+ Supplements: NMN vs NR vs NAD+ – What Actually Works?

NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are NAD+ precursors: your cells turn NR into NMN and NMN into NAD+, while NAD+ swallowed as a capsule is largely broken down in the gut before it reaches the blood. NR has the most human trial data, with studies reporting blood NAD+ rises of roughly 40 to 90 percent at 300 to 1,000 mg a day, and no head-to-head trial has yet shown NMN or NR to be clearly better than the other.

NAD+ (nicotinamide adenine dinucleotide) is the coenzyme both supplements aim to raise. NMN sits one enzymatic step from NAD+, NR sits two steps away, and niacin (vitamin B3) reaches NAD+ through a separate, longer route. The sections below compare each option by pathway, human evidence, typical dose, side effects and cost, then cover whether NR and NMN can be taken together and when NAD+ IV therapy is a different conversation.

Why NAD+ Supplements Have Exploded in Popularity

NAD+ has become one of the most discussed molecules in longevity research over the last five years. Nicotinamide adenine dinucleotide is a coenzyme found in every living cell, and it plays a central role in energy metabolism, DNA repair and cellular signaling. Enzymes such as sirtuins, PARPs and CD38 consume NAD+ as they work, so the cell has to keep rebuilding it.

NAD+ levels decline as we age. By some estimates, levels in certain tissues drop by roughly 50 percent between your thirties and your sixties, although the size of the decline varies by tissue and by study.

That decline has fueled a large supplement market. Health food stores and online retailers carry dozens of products that promise to restore NAD+ levels: NMN, NR, niacin, "liposomal NAD+" and sublingual tablets among them. The marketing claims can be hard to separate from the actual evidence.

This guide breaks down each major NAD+ precursor, compares them head to head, and gives an evidence-based assessment of what works and when you might need something other than a capsule.

Understanding NAD+ Biosynthesis: Three Pathways Your Body Uses

Your body makes NAD+ through three primary biosynthetic routes, and each supplement enters a different one. Knowing which route a product uses explains most of the differences in dose, side effects and evidence.

1. The Salvage Pathway (Primary)

The salvage pathway is the workhorse. Your body constantly recycles nicotinamide (NAM), a byproduct of NAD+ consumption by enzymes like sirtuins and PARPs, back into NAD+. The enzyme NAMPT converts NAM into NMN, and then NMNAT enzymes convert NMN into NAD+.

Both NR and NMN feed directly into this pathway, which is why they are the two most popular supplement choices. NR joins through a side door: the enzyme NRK (nicotinamide riboside kinase) adds a phosphate to turn it into NMN.

2. The Preiss-Handler Pathway

This route uses nicotinic acid (niacin, or vitamin B3) as its starting material. Niacin is converted to nicotinic acid mononucleotide (NaMN), then to nicotinic acid adenine dinucleotide (NaAD), and finally to NAD+.

It works, but it is a longer route and comes with the well-known "niacin flush": skin flushing, tingling and redness that many people find intolerable at higher doses.

3. The De Novo Pathway

Starting from the amino acid tryptophan, found in turkey, eggs and other protein-rich foods, your body can build NAD+ from scratch. This pathway is highly inefficient: it takes roughly 60 mg of tryptophan to produce just 1 mg of niacin equivalent. It contributes a small baseline supply but is not a practical supplementation strategy for boosting NAD+.

The Major NAD+ Precursors Compared

NMN (Nicotinamide Mononucleotide)

NMN is one enzymatic step away from NAD+ itself. After oral ingestion, NMN is absorbed in the gut. Research by Grozio and colleagues in Nature Metabolism (2019) identified a transporter protein called Slc12a8 that can shuttle NMN directly into cells in mice, though there is ongoing debate about how significant this direct transport is in humans.

NMN gained mainstream visibility through Harvard geneticist David Sinclair, who has publicly discussed taking NMN himself (typically 1,000 mg daily) and whose lab has produced some of the most cited NAD+ research. His lab's 2013 paper in Cell, led by Ana Gomes, reported that raising NAD+ with NMN restored markers of mitochondrial function in older mice, a landmark moment for the field.

On the clinical side, NMN human trials have grown quickly since 2021. A notable study by Yoshino and colleagues at Washington University in St. Louis, published in Science in 2021, showed that NMN improved muscle insulin sensitivity in prediabetic postmenopausal women. Other human trials have reported improvements in aerobic capacity, sleep quality and physical performance, though sample sizes remain small and long-term data is still accumulating.

NR (Nicotinamide Riboside)

NR enters the salvage pathway one step before NMN. It must first be converted to NMN by the enzyme NRK (nicotinamide riboside kinase), and then NMN is converted to NAD+. Despite this extra step, NR has the longer track record in human clinical research.

The first human pharmacokinetic study, by Trammell and colleagues in Nature Communications (2016), found that NR is orally bioavailable in mice and humans. The patented NR ingredient sold commercially has since been used in more than 30 published human clinical trials. These studies have consistently shown that NR supplementation (typically 300 to 1,000 mg daily) raises blood NAD+ levels by roughly 40 to 90 percent depending on the dose, with a favorable safety profile.

Key NR findings from human trials include improvements in blood NAD+ biomarkers, favorable safety profiles even at higher doses, and preliminary signals in cardiovascular and metabolic health. One 2018 trial by Martens and colleagues, published in Nature Communications, showed that NR was well tolerated and elevated NAD+ in healthy middle-aged and older adults. Some commercial products pair NR with pterostilbene, a resveratrol relative, and have their own smaller body of published research.

Niacin (Nicotinic Acid / Vitamin B3)

Plain niacin is the cheapest option, and it does raise NAD+ levels via the Preiss-Handler pathway. It has decades of research behind it, primarily for cardiovascular health and cholesterol management rather than longevity. The major drawback is the niacin flush, which can range from mildly annoying to quite uncomfortable.

Extended-release niacin reduces flushing but raises concerns about liver toxicity at higher doses. Niacinamide (nicotinamide) avoids the flush but can inhibit sirtuins at high doses, which works against the purpose if sirtuin activation is your goal.

Oral NAD+ (Direct)

Some companies sell NAD+ itself in capsule form. The fundamental challenge is bioavailability: NAD+ is a large, charged molecule that does not cross cell membranes efficiently and is largely degraded in the gastrointestinal tract.

Some of these products use liposomal encapsulation or sublingual delivery to try to bypass gut degradation. The evidence that meaningful amounts of intact NAD+ reach the bloodstream via oral administration is very limited.

Head-to-Head Comparison Table

NMN, NR, niacin and oral NAD+ differ mainly in which pathway they enter, how many enzymatic steps separate them from NAD+, and how much human trial data supports them. The table summarizes each attribute side by side.

The NMN vs NR Debate: Which One Should You Take?

Both NMN and NR effectively raise NAD+ levels in humans, and both have favorable safety profiles at standard doses. The question dominates longevity forums, but the real differences come down to nuance rather than a clear winner.

The case for NR: NR has a larger body of published human clinical data. For readers who weigh the volume of human evidence most heavily, NR is the more conservative choice. The leading NR ingredient has Generally Recognized as Safe (GRAS) status notified to the FDA and has been used in a broad range of clinical research settings.

The case for NMN: NMN is one step closer to NAD+ in the biosynthetic pathway, and some researchers argue this gives it a theoretical efficiency advantage. David Sinclair's advocacy has driven strong research interest, and the pace of new NMN human trials is accelerating. If the trajectory of the science matters to you, NMN's clinical evidence base is catching up.

The practical reality: No definitive head-to-head human trial shows one is clearly superior for raising NAD+ or improving health outcomes. Some research, including work by Ratajczak and colleagues in Nature Communications (2016), suggests NMN is often converted to NR outside cells before absorption, then rephosphorylated to NMN inside cells. If that holds in people, the distinction between taking NMN and NR orally may be partly academic.

For a closer look at the two precursors alone, our NMN vs NR comparison goes deeper into the trial-by-trial data.

NMN vs NAD+: Why Take a Precursor Instead of NAD+ Itself?

NMN is a precursor that cells convert into NAD+ in one step, while NAD+ is the finished coenzyme. Taking NMN orally is the more practical route because NMN is smaller and is absorbed in the gut, whereas oral NAD+ is a large, charged molecule that is mostly broken down in the digestive tract before it reaches the blood.

This is why searches for "NMN vs NAD" or "NAD or NMN" usually land on the same answer. If the goal is to raise NAD+ with a daily capsule, a precursor such as NMN or NR has far more human data than an NAD+ capsule. NAD+ given intravenously is a different case, because IV delivery skips digestion entirely.

NADH vs NMN: How the Reduced Form Compares

NADH is the reduced form of NAD+: the same coenzyme after it has picked up electrons during energy metabolism. Cells constantly cycle between NAD+ and NADH, so NADH is not a precursor in the way NMN and NR are.

Oral NADH supplements face the same bioavailability problem as oral NAD+, because NADH is also a large molecule that the gut breaks down. Small trials have tested oral NADH in conditions such as chronic fatigue syndrome, but the evidence is thin. For raising cellular NAD+, NMN and NR have a much larger and more consistent body of human research than NADH.

Can You Take NR and NMN Together?

You can take NR and NMN together, and no published study has flagged a safety problem with combining them, but no trial has tested the combination either. Both feed the same salvage pathway and converge on NMN inside cells, so taking both mostly adds to the total precursor dose rather than adding a separate benefit.

For that reason, most clinicians who use these supplements choose one precursor at a studied dose rather than stacking two. If you do combine them, count the total daily amount against the ranges used in trials (NR 300 to 1,000 mg, NMN 500 to 1,000 mg) rather than taking a full dose of each. Our NAD+ dosage guide covers how doses are chosen across oral and IV forms.

What NAD+ boosting strategies are compared besides NMN and NR?

The main NAD+ boosting strategies are oral precursors (NMN, NR and niacin), oral NAD+ or NADH, NAD+ given by IV infusion or injection, and approaches that slow NAD+ breakdown, such as CD38 inhibitors studied in the lab. Lifestyle factors such as regular exercise also influence NAD+ metabolism. Of these, NR and NMN have the most human data for raising blood NAD+ by mouth.

Delivery Methods: Liposomal, Sublingual, and Standard Capsules

Beyond choosing which precursor to take, you will encounter three main delivery formats. Standard capsules have the strongest evidence; the other two rest mostly on theory and manufacturer data.

Standard oral capsules are the most common and most studied. The clinical trials that established NR and NMN effects on NAD+ overwhelmingly used standard oral forms, and they raise blood NAD+ reliably.

Sublingual tablets or powders dissolve under the tongue and are absorbed through the mucous membranes, partially bypassing first-pass liver metabolism. Some users and clinicians report faster subjective effects, but strong comparative bioavailability data is sparse.

Liposomal formulations encapsulate the active ingredient in lipid spheres to protect it from digestive degradation and enhance absorption. This approach has theoretical backing and has shown benefits in other supplement categories, liposomal vitamin C for example. For NAD+ precursors, liposomal delivery is relatively new, and independent peer-reviewed comparisons are limited.

When Supplements Are Enough, and When They Are Not

Oral NAD+ precursors are a reasonable starting point for general wellness and healthy aging goals. If you are relatively healthy, in your thirties or forties, and looking to maintain NAD+ levels as a proactive measure, a quality NMN or NR supplement at standard doses is a sensible foundation. A baseline blood panel is the only way to tell whether what you are taking is moving the markers you care about, and services such as BioProfile in Europe have a doctor read that panel before suggesting changes.

There are situations where supplements may not be sufficient:

• Significant NAD+ depletion: chronic illness, addiction recovery or advanced age may create a deficit that oral precursors cannot address quickly.
• Acute therapeutic goals: if you are seeking rapid neurological, metabolic or recovery effects, the slow oral absorption rate limits how fast you can raise tissue NAD+ levels.
• Bioavailability ceiling: oral supplements must survive digestion, undergo first-pass metabolism in the liver, and compete with other metabolic demands. IV delivery bypasses all of these barriers.

This is where NAD+ IV therapy enters the picture. Intravenous delivery provides 100 percent bioavailability and can achieve blood NAD+ levels that oral supplements cannot match. For a complete overview of NAD+ IV therapy, including protocols, benefits and what to expect, see our thorough NAD+ IV Therapy guide.

NAD+ infusions are cash pay at most clinics and are not FDA approved for the longevity, fatigue or recovery uses patients usually ask about, so the evidence for those uses is thinner than the marketing suggests. They are typically offered by integrative and functional medicine physicians, IV therapy clinics and some addiction medicine programs. Readers weighing the two routes can compare NAD+ IV versus oral supplements side by side, or browse clinics that offer NAD+ IV therapy in the directory. Regenerated.com is free for patients, and listing order there is not paid ranking.

Quality and Sourcing: What to Look For

Supplement quality varies widely, and dietary supplements are not reviewed by the FDA for purity or effectiveness before they are sold. When shopping for NMN or NR, look for these markers:

• Third-party testing: certificates of analysis (COAs) from independent labs verifying purity and potency.
• GMP certification: manufactured in facilities that follow Good Manufacturing Practices.
• Clinically studied ingredients: for NR, choose the patented ingredient form used in the published human trials. For NMN, look for products made by enzymatic synthesis (rather than chemical synthesis) with transparent testing results.
• Proper storage: NMN in particular can degrade with heat and moisture. Some sellers use cold-chain shipping and recommend refrigeration.
• Regulatory status: whether NMN can be sold as a dietary supplement in the US has been disputed with the FDA since 2022, so availability and labeling of NMN products can change.

Cost Comparison: Monthly Investment by Approach

Niacin is the least expensive way to raise NAD+, NR and NMN cost several times more, and NAD+ IV therapy costs the most per month. The ranges below are approximate retail figures and vary by product, dose and clinic.

Clinic pricing for infusions depends on dose, session length and location; our NAD+ IV therapy treatment guide explains what drives the difference.

Frequently asked questions

Is NMN or NR better for raising NAD+ levels?

Neither has been shown to be better, because no head-to-head human trial has compared them directly. Both raise blood NAD+ levels in clinical studies. NR has more published human trial data, with rises of roughly 40 to 90 percent reported at 300 to 1,000 mg a day, while NMN has strong preclinical data and a fast-growing set of human studies. Either is a reasonable choice when it is third-party tested and taken at a studied dose.

Can you take NR and NMN together?

Yes, you can take NR and NMN together, but no clinical trial has tested the combination or shown an added benefit. Both enter the same salvage pathway and become NMN inside cells, so combining them mainly increases the total precursor dose. Most people choose one precursor at a studied dose, such as NR 300 to 1,000 mg or NMN 500 to 1,000 mg a day. If you combine them, keep the combined total within those ranges and tell your clinician.

Can I just take regular niacin instead of NMN or NR?

Niacin does raise NAD+ levels and costs far less, roughly $5 to $15 a month. The flushing side effect limits tolerability at higher doses, and extended-release niacin carries liver toxicity concerns. Niacin also uses a different route, the Preiss-Handler pathway, which some researchers believe may not support sirtuin activity as effectively as the salvage pathway used by NMN and NR. For people who tolerate it, niacin remains a low-cost, long-studied option.

Does David Sinclair still take NMN?

David Sinclair, the Harvard geneticist, has described taking 1,000 mg of NMN daily as part of his personal longevity regimen in his most recent public statements. His advocacy is informed by his lab's research, including the 2013 Cell study in older mice, but it represents his personal approach, not a clinical recommendation. The broader scientific community continues to evaluate NMN in randomized human trials, and long-term human outcome data is not yet available.

Should I take NAD+ supplements if I am also doing NAD+ IV therapy?

Many clinicians recommend daily oral NMN or NR between IV sessions to help maintain NAD+ levels. The infusions provide periodic high-level boosts, while a daily precursor helps sustain baseline levels between treatments. This combination is common in practice, but it has not been tested in controlled trials, so the protocol rests on clinical judgment. Discuss the specific dose and schedule with the clinician who manages your infusions.

Are there any safety concerns with long-term NMN or NR use?

Published clinical trials, ranging from weeks to several months, have not identified significant safety concerns for NMN or NR at standard doses, and both are generally well tolerated. Truly long-term safety data, covering five or more years of daily use, does not yet exist for either compound. Some researchers have raised a theoretical concern that excess NAD+ could support cancer cell metabolism, but this has not been demonstrated in human supplementation studies at standard doses.

Related Reading

• NAD+ IV Therapy: The Complete Guide: our complete pillar guide covering everything about NAD+ IV therapy, from mechanisms to protocols.
• NAD+ for Anti-Aging: What the Science Actually Shows: a deep dive into the longevity research behind NAD+ and what it realistically means for aging.
• NAD+ Drip Therapy: Cost, Duration, and What to Expect: a practical walkthrough of what happens during a clinic-based NAD+ IV session.